Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Asset Utilization Ratio (2016 - 2025)

Historic Asset Utilization Ratio for Editas Medicine (EDIT) over the last 10 years, with Q3 2025 value amounting to 0.22.

  • Editas Medicine's Asset Utilization Ratio rose 2975.47% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.22, marking a year-over-year increase of 2975.47%. This contributed to the annual value of 0.08 for FY2024, which is 5013.89% down from last year.
  • According to the latest figures from Q3 2025, Editas Medicine's Asset Utilization Ratio is 0.22, which was up 2975.47% from 0.16 recorded in Q2 2025.
  • Over the past 5 years, Editas Medicine's Asset Utilization Ratio peaked at 0.22 during Q3 2025, and registered a low of 0.03 during Q3 2021.
  • Over the past 5 years, Editas Medicine's median Asset Utilization Ratio value was 0.1 (recorded in 2024), while the average stood at 0.1.
  • Its Asset Utilization Ratio has fluctuated over the past 5 years, first tumbled by 7725.79% in 2021, then skyrocketed by 32311.91% in 2024.
  • Editas Medicine's Asset Utilization Ratio (Quarter) stood at 0.04 in 2021, then increased by 2.94% to 0.04 in 2022, then skyrocketed by 312.75% to 0.16 in 2023, then crashed by 37.95% to 0.1 in 2024, then skyrocketed by 132.95% to 0.22 in 2025.
  • Its Asset Utilization Ratio stands at 0.22 for Q3 2025, versus 0.16 for Q2 2025 and 0.12 for Q1 2025.